(Q43980571)

28 November 2017

title

High expression of epithelial cellular adhesion molecule in peritoneal metastasis of gastric cancer (English)

1 reference

28 November 2017

Motohiro Imano

1

1 reference

28 November 2017

Tatsuki Itoh

2

1 reference

28 November 2017

Takao Satou

3

1 reference

28 November 2017

Atsushi Yasuda

4

1 reference

28 November 2017

Kohei Nishiki

5

1 reference

28 November 2017

Hiroaki Kato

6

1 reference

28 November 2017

Osamu Shiraishi

7

1 reference

28 November 2017

Ying-Feng Peng

8

1 reference

28 November 2017

Masayuki Shinkai

9

1 reference

28 November 2017

Masahiro Tsubaki

10

1 reference

28 November 2017

Takushi Yasuda

11

1 reference

28 November 2017

Haruhiko Imamoto

12

1 reference

28 November 2017

Shozo Nishida

13

1 reference

28 November 2017

Yoshifumi Takeyama

14

1 reference

28 November 2017

Hiroshi Furkawa

15

1 reference

28 November 2017

Kiyokata Okuno

16

1 reference

28 November 2017

Hitoshi Shiozaki

17

1 reference

28 November 2017

publication date

17 November 2012

1 reference

28 November 2017

1 reference

28 November 2017

volume

8

1 reference

28 November 2017

issue

4

1 reference

28 November 2017

page(s)

231-235

1 reference

Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

EpCAM (CD326) finding its role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

Catumaxomab: clinical development and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

Prognostic significance of Ep-CAM AND Her-2/neu overexpression in invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

EpCAM is overexpressed in gastric cancer and its downregulation suppresses proliferation of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

Evaluation of a panel of molecular markers for the diagnosis of malignant serous effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

Expression of Ep-CAM shifts the state of cadherin-mediated adhesions from strong to weak

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

EpCAM: a potential antimetastatic target for gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

Safety of intraperitoneal administration of paclitaxel after gastrectomy with en-bloc D2 lymph node dissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

Prowling wolves in sheep's clothing: the search for tumor stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

Adjuvant Therapy with Edrecolomab versus Observation in Stage II Colon Cancer: A Multicenter Randomized Phase III Study*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0239-4

A preliminary study of single intraperitoneal administration of paclitaxel followed by sequential systemic chemotherapy with S-1 plus paclitaxel for advanced gastric cancer with peritoneal metastasis

21 January 2018

1 reference

12 December 2020

Utility of BER-EP4 in the diagnosis of adenocarcinoma in effusions: an immunocytochemical study of 232 cases

1 reference

12 December 2020

Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study

1 reference

12 December 2020

Cancer spheres from gastric cancer patients provide an ideal model system for cancer stem cell research

1 reference

12 December 2020

Immunocytochemical staining of serous effusions with the monoclonal antibody Ber-EP4

1 reference

12 December 2020

10.1007/S11523-012-0239-4

Identifiers

DOI

1 reference

28 November 2017

1 reference